Intelligence · Clinical Development
Pipeline search results
Programs matching “ticagrelor” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 20 pipeline programs matching "ticagrelor" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
De-escalation to ticagrelor 60 mg at day 30
COLLEGIUM PHARMACEUTICAL, INC
Non ST Segment Elevation Acute Coronary Syndrome
1 trial -
Ticagrelor
AstraZeneca
Acute Coronary Syndrome
1 trial -
Ticagrelor 90 mg
AstraZeneca
Myocardial Infarction
1 trial -
Ticagrelor 90 mg
COLLEGIUM PHARMACEUTICAL, INC
Myocardial Infarction
1 trial -
Ticagrelor 90mg
COLLEGIUM PHARMACEUTICAL, INC
STEMI
1 trial -
Ticagrelor and Aspirin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stroke
1 trial -
ticagrelor
The First People's Hospital of Lianyungang
Coronary Artery Disease
1 trial -
Crushed ticagrelor followed by morphine
COLLEGIUM PHARMACEUTICAL, INC
Unstable Angina Pectoris
2 trials -
Pulverized ticagrelor sublingually
COLLEGIUM PHARMACEUTICAL, INC
Unstable Angina Pectoris
1 trial -
TICAGRELOR
Disc Medicine
Acute coronary syndrome
1 trial -
Ticagrelor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
Ticagrelor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Ticagrelor followed with Methoxyflurane
COLLEGIUM PHARMACEUTICAL, INC
Unstable Angina
1 trial -
half-dose ticagrelor
The First People's Hospital of Lianyungang
Acute Coronary Syndrome
1 trial -
low-dose ticagrelor
The First People's Hospital of Lianyungang
Platelet Reactivity
1 trial -
low-dose ticagrelor
The First People's Hospital of Lianyungang
Coronary Artery Disease
1 trial -
ticagrelor
The First People's Hospital of Lianyungang
Inflammation
1 trial -
ticagrelor + ASA
Peking University Third Hospital
Cerebrovascular Accident
1 trial -
Ticagrelor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Brain Disease
1 trial -
Ticagrelor monotherapy
The First People's Hospital of Lianyungang
Intracranial Aneurysm
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.